Viewing Study NCT04624958


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2025-12-25 @ 10:26 PM
Study NCT ID: NCT04624958
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-18
First Post: 2020-11-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCL
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module